treatment of myasthenia gravis
All entries for: Dianthus Therapeutics, Inc
May 1, 2026
Dianthus Therapeutics, Inc
Designated
New York, NY
1-50 employees
Disease Area: Rare Disease
March 9, 2026
Dianthus Therapeutics, Inc
Neutral Outlook
New York, NY
1-50 employees
Notwithstanding these provisions, the IRA’s impact on commercialization and competition remains largely uncertain.
Disease Area: Dermatology, Immune Diseases, Neurological Diseases, Rare Diseases
Drug Type: Biologic